Bortezomib maintenance after R‐CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial

Rituximab‐containing induction followed by autologous stem cell transplantation (ASCT) is the standard first‐line treatment for young mantle cell lymphoma patients. However, most patients relapse after ASCT. We investigated in a randomised phase II study the outcome of a chemo‐immuno regimen and ASC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Doorduijn, Jeanette K., Zijlstra, Josee M., Lugtenburg, Pieternella J., Kersten, Marie Josee, Böhmer, Lara H., Minnema, Monique C., MacKenzie, Marius A., van Marwijk Kooij, Rien, de Jongh, Eva, Snijders, Tjeerd J.F., de Weerdt, Okke, van Gelder, Michel, Hoogendoorn, Mels, Leys, Rineke B.L., Kibbelaar, Robby E., de Jong, Daphne, Chitu, Dana A., Van’t Veer, Mars B., Kluin‐Nelemans, Hanneke C.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Haematological Malignancy ‐ Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496560/
https://ncbi.nlm.nih.gov/pubmed/32150297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16567
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados